0.98 ML Yorvipath 0.3 MG/ML Pen Injector
- RxCUI
- 2693646
- RxNorm name
- 0.98 ML Yorvipath 0.3 MG/ML Pen Injector
- Display name
- 0.98 ML Yorvipath 0.3 MG/ML Pen Injector
- Full name
- 0.98 ML Yorvipath 0.3 MG/ML Pen Injector
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:11
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Yorvipath | PALOPEGTERIPARATIDE | Ascendis Pharma, Endocrinology, Inc. | a1fa23fd-c434-443e-9a17-5750578c8602 | 2026-08-12 | Warnings, Adverse reactions | 2693646 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a1fa23fd-c434-443e-9a17-5750578c8602 | Yorvipath 294 MCG in 0.98 ML Pen Injector [PSN] · 0.98 ML teriparatide 0.3 MG/ML Pen Injector [Yorvipath] [SBD] · 0.98 ML Yorvipath 0.3 MG/ML Pen Injector [SY] · Yorvipath 294 MCG per 0.98 ML Pen Injector [SY] | 4 | 7 | These highlights do not include all the information needed to use YORVIPATH safely and effectively. See full prescribing information for YORVIPATH. YORVIPATH ® (palopegteriparatide) injection, for subcutaneous use Initial U.S. Approval: 2024 | 20260421 |